The Use of Lithium in the Affective Psychoses
Abstract
Lithium carbonate has been used with caution and control at the New York State Psychiatric Institute for the past six years. Nineteen patients, 15 of whom had at least two well-documented prior manic attacks, were given 25 trials of lithium after therapeutic refractoriness on phenothiazines. Eleven of the 25 manic episodes had good responses to lithium treatment; the individual manic attack was definitely shortened as compared with the patient's past attacks. The authors suggest that lithium may be the treatment of choice for phenothiazine-refractory or phenothiazine-allergic manic patients treated in a research setting.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
